Episode 375: 386. Could half dose anticoagulation be the answer?

Episode 375: 386. Could half dose anticoagulation be the answer?

  • Estimated 5-year incidence of recurrent VTE was similar in the reduced-dose and full-dose groups (2.2% and 1.8%).

  • Estimated 5-year bleeding incidence was significantly lower with reduced-dose than with full-dose treatment (2.1% vs. 4.0% for major bleeding; 8.6% vs. 11.5% for clinically relevant nonmajor bleeding).

  • Outcomes with apixaban and rivaroxaban were similar.

Couturaud F et al. Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: A non-inferiority, multicentre, randomised, open-label, blinded endpoint trial. Lancet 2025 Mar 1; 405:725. (https://doi.org/10.1016/S0140-6736(24)02842-3)


Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(401)

Populärt inom Hälsa

husmodern-med-amanda-schulman
somna-med-henrik
rss-bara-en-till-om-beroende-medberoende
rss-jossan-nina
inga-beiga-morsor
rss-vuxna-pa-latsas
not-fanny-anymore
rss-viktmedicinpodden
sexnoveller-deluxe
angestpodden
rss-hos-psykologen
sova-med-dan-horning
rss-ronden
johannes-hansen-podcast
sa-in-i-sjalen
rss-basta-livet
rss-lattsamt-med-kp
dodsdomar
rss-lyckopodden
till-sangs